This study examined how acceptability of placebo gel with receptive anal intercourse (RAI) and likelihood of future rectal microbicide use varied across partner types. Since no rectal microbicide is available yet, use of placebo permitted the study of gel use behavior in real-life circumstances. Eighty-seven men who have sex with men aged 18 to 30 years inserted placebo gel rectally before RAI during 12 weeks. Using mixed-methods design, participants completed a behavioral questionnaire and in-depth interview. Sixty-two men (71.3%) reported gel use with a lover (i.e., spouse-equivalent, boyfriend), 32 (36.8%) with a one-night stand (i.e., man with whom you had sex once), and 29 (33.3%) with an “other” male partner. While gel acceptability was high across partner types, use with lovers was facilitated by trust and familiarity; yet, trust made participants believe protection was less necessary. Conversely, participants expressed high likelihood of using gel with one-night-stands, whom they perceived as riskier; yet, they felt less comfortable discussing gel with them, often resorting to covert use or foregoing gel. A successful microbicide will be positioned as a sexual pleasure enhancer, so that men can present it to lovers and other partners as a gel that improves sex, and secondarily prevents HIV.